MedPath

Assessing brain hemodynamics using Arterial Spin Labeling MRI.

Withdrawn
Conditions
Cerebrovascular disease
stroke
10003216
Registration Number
NL-OMON35194
Lead Sponsor
niversitair Medisch Centrum Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
160
Inclusion Criteria

(p. 15 protocol)
> 18 year
informed consent
Intracranial occlusion
Extracranial occlusion
Extracranial stenosis
In stroke patients, MRI scan within one week of symptom onset

Exclusion Criteria

(p.15 protocol)
Contraindications for MRI (claustrophobia, or standard MRI contraindications such as pacemakers or specific metal objects in or around the body)
Unwilling or unable to co-operate with breathing manoeuvres
Respiratory or cardiac limitations to breathing at 20L/min
Medical contra-indications to limited hypercapnia (known increased intracerebral pressure, metabolic acidosis or alkalosis)
Altered consciousness
Non compliance with prescribed anti-seizure medication

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Our objective is to test the feasibility of the application of a CO2-challenge<br /><br>to measure Cerebrovascular Reactivity in healthy subjects and in<br /><br>cerebrovascular diseased patients with Arterial Spin Labeling MRI and to test<br /><br>the feasibility of a Velocity-Selective Spin Labeling sequence to measure the<br /><br>Cerebral Metabolic Rate of Oxygen. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>To obtain baseline values of these two parameters in a healthy control group<br /><br>and in patients with cerebrovascular disease.</p><br>
© Copyright 2025. All Rights Reserved by MedPath